中国神经再生研究(英文版)

神经退行性病

1.	STAT3 ameliorates truncated tau-induced cognitive deficits (2023-09-16)
2.	Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons (2023-09-16)
3.	Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis (2023-09-02)
4.	One-step cell biomanufacturing platform: porous gelatin microcarrier beads promote human embryonic stem cell-derived midbrain dopaminergic progenitor cell differentiation in vitro and survival after transplantation in vivo (2023-08-30)
5.	Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells (2023-08-02)
6.	The MORC2 p.S87L mutation reduces proliferation of pluripotent stem cells derived from a patient with the spinal muscular atrophy-like phenotype by inhibiting proliferation-related signaling pathways (2023-08-02)
7.	CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in in vitro and in vivo models of Parkinson’s disease (2023-08-02)
8.	Biomaterials-based anti-inflammatory treatment strategies for Alzheimer’s disease (2023-08-02)
9.	Ketogenic diet alleviates cognitive dysfunction and neuroinflammation in APP/PS1 mice via the Nrf2/HO-1 and NF-κB signaling pathways (2023-06-16)
10.	Rapamycin reverses ferroptosis by increasing autophagy in MPTP/MPP+-induced models of Parkinson’s disease (2023-05-05)
11.	Long-term radiofrequency electromagnetic fields exposure attenuates cognitive dysfunction in 5×FAD mice by regulating microglial function (2023-05-05)
12.	Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson’s disease and neuronal damage through inhibition of microglia (2023-03-29)
13.	5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis (2023-03-07)
14.	Single-nuclei RNA sequencing uncovers heterogenous transcriptional signatures in Parkinson’s disease associated with nuclear receptor-related factor 1 defect (2023-03-07)
15.	Inhibiting 5-hydroxytryptamine receptor 3 alleviates pathological changes of a mouse model of Alzheimer’s disease (2023-03-07)
16.	Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson’s disease (2023-02-27)
17.	Emodin attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis (2023-01-12)
18.	A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G (2023-01-12)
19.	Overexpression of fibroblast growth factor 13 ameliorates amyloid-β-induced neuronal damage (2023-01-05)
20.	The relationship among amyloid-β deposition, sphingomyelin level, and the expression and function of P-glycoprotein in Alzheimer’s disease pathological process (2023-01-05)
21.	Neural regeneration research model to be explored: SH-SY5Y human neuroblastoma cells (2023-01-05)
22.	Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease (2022-11-01)
23.	Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease (2022-11-01)
24.	Neural progenitor cells derived from fibroblasts induced by small molecule compounds under hypoxia for treatment of Parkinson’s disease in rats (2022-11-01)
25.	TMEM16F may be a new therapeutic target for Alzheimer’s disease (2022-08-29)
26.	The Alzheimer’s disease-associated gene TREML2 modulates inflammation by regulating microglia polarization and NLRP3 inflammasome activation (2022-07-20)
27.	Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease (2022-06-17)
28.	DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson’s disease (2022-06-17)
29.	Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer’s disease (2022-06-17)
30.	Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice (2022-06-17)
31.	Dysregulated expression and distribution of Kif5α in neurites of wobbler motor neurons (2022-06-17)
32.	Aquaporin 4 deficiency eliminates the beneficial effects of voluntary exercise in a mouse model of Alzheimer’s disease (2022-03-10)
33.	Abnormal characterization of dynamic functional connectivity in Alzheimer’s disease (2022-03-10)
34.	Endocannabinoid metabolism and Alzheimer’s disease (2022-03-10)
35.	Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet (2022-03-10)
36.	The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer’s disease (2022-03-10)
37.	Perspective on the relationship between microbiota dysbiosis and neuroinflammation: probiotics as a treatment option (2022-03-10)
38.	Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis? (2022-03-10)
39.	Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer’s disease (2022-03-10)
40.	Role of exosomes in the pathogenesis of inflammation in Parkinson’s disease (2022-03-10)

跳至
页
第1页
共6页
共233条记录